Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC STGW Stagwell Inc 13G/A 16.8% 2y
Voon Him Hoo VCIG VCI Global Ltd 13G/A 23.42% 2y
Kelcy L. Warren ET Energy Transfer LP 13D/A 8.8% 2y
Deep Track Capital, LP DVAX Dynavax Technologies Corporation 13D 9.56% 2y
Velan Capital Investment Management LP ALIM Alimera Sciences, Inc. 13D/A 0% 2y
Amit Agarwal TCS THE CONTAINER STORE GROUP, INC. 13G/A 12.86% 2y
Ocho Investments LLC TBRG TruBridge, Inc. 13D/A 6.7% 2y
Herr Investment Group LLC LINC Lincoln Educational Services Corp 13G 0% 2y
Mithaq Capital SPC PLCE Childrens Place, Inc. 13D/A 55.1% 2y
Sentient Global Resources Fund IV, L.P. AUMN Golden Minerals Co 13D/A 4.54% 2y
DGP Co., Ltd. XCUR Exicure, Inc. 13D/A 39.1% 2y
Kamal Seyed Ghaffarian LUNR Intuitive Machines, Inc. 13D/A 43.9% 2y
Joshua Harley FTHM Fathom Holdings Inc. 13D/A 21.2% 2y
Hsieh Anthony Li LDI loanDepot, Inc. 13D/A 58.9% 2y
Vitruvian Partners LLP WKME WalkMe Ltd. Ordinary Shares 13D/A 0% 2y
American Industrial Partners Capital Fund VI, L.P. VVX V2X, Inc. 13D/A 53.2% 2y
RA CAPITAL MANAGEMENT, L.P. JANX Janux Therapeutics, Inc. 13D/A 19.99% 2y
RA CAPITAL MANAGEMENT, L.P. FULC Fulcrum Therapeutics, Inc. 13G/A 19.3% 2y
ORBIMED ADVISORS LLC TERN Terns Pharmaceuticals, Inc. 13D/A 9% 2y
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP CMMB Chemomab Therapeutics Ltd. 13D/A 9.99% 2y
Jay Lichter, Ph.D. (“Lichter”) JANX Janux Therapeutics, Inc. 13D/A 12.7% 2y
CVI Investments, Inc. BCTX BriaCell Therapeutics Corp. 13G 8.5% 2y
Harraden Circle Investments, LLC BAYA Bayview Acquisition Corp 13G 7.2% 2y
BML Investment Partners, L.P. ORMP Oramed Pharmaceuticals Inc. 13G 5% 2y
D2BW Ltd ARQQ Arqit Quantum Inc. 13D/A 19.2% 2y
Shell plc XCH XCHG Ltd 13G 8.4% 2y
Beryl Capital Management LLC RVNC Revance Therapeutics, Inc. 13G 1.6% 2y
ATW Growth Opportunities SPV, LLC FFAI Faraday Future Intelligent Electric Inc. 13G 9.9% 2y
Denali Capital Global Investments LLC SMNR Semnur Pharmaceuticals, Inc. 13G/A 65.6% 2y
SailingStone Capital Partners LLC NRGV Energy Vault Holdings, Inc. 13G 5.41% 2y
SailingStone Capital Partners LLC CMP Compass Minerals International Inc 13G 6.46% 2y
Think Investments LP TASK TaskUs, Inc. 13G 7.6% 2y
GDD International Holding Company GDYN Grid Dynamics Holdings, Inc. 13D/A 18.1% 2y
Ariel Emanuel TKO TKO Group Holdings, Inc. 13D/A 53.5% 2y
Conestoga Capital Advisors, LLC TRNS Transcat Inc 13G/A 10.38% 2y
Saba Capital Management, L.P. PGZ Principal Real Estate Income Fund 13D/A 7.3% 2y
GAMCO INVESTORS, INC. ET AL LEN Lennar Corp 13D/A 3.68% 2y
David S. Lobel HLLY Holley Inc. 13D/A 36.2% 2y
KTR Management Company, LLC SEI Solaris Energy Infrastructure, Inc. 13D 21.1% 2y
JS Capital Management LLC PACK Ranpak Holdings Corp. 13D/A 38% 2y
Manuel Chavez, III BEEP Mobile Infrastructure Corp 13D/A 53.39% 2y
Thomas Bradley STEP StepStone Group Inc. 13D/A 4.9% 2y
Robert W. Duggan SMMT Summit Therapeutics Inc. 13D/A 75.2% 2y
Monte M. Brem STEP StepStone Group Inc. 13D/A 41.8% 2y
Fairmount Funds Management LLC ORKA Oruka Therapeutics, Inc. 13D/A 19.99% 2y
Fund 1 Investments, LLC VRA Vera Bradley, Inc. 13D/A 8.7% 2y
Mark Maruszewski STEP StepStone Group Inc. 13D/A 4.8% 2y
J Turbines, Inc. SEI Solaris Energy Infrastructure, Inc. 13D 21.1% 2y
Tether Holdings Limited BTDR Bitdeer Technologies Group 13D/A 25.7% 2y
DENG, SHUFEN REED Reed's, Inc. 13D/A 55.4% 2y